Hosking Partners LLP grew its holdings in shares of Trupanion, Inc. (NASDAQ:TRUP - Free Report) by 86.9% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 397,656 shares of the financial services provider's stock after acquiring an additional 184,936 shares during the period. Hosking Partners LLP owned about 0.93% of Trupanion worth $14,821,000 as of its most recent SEC filing.
Other large investors have also recently modified their holdings of the company. Marshall Wace LLP grew its holdings in shares of Trupanion by 6.9% during the fourth quarter. Marshall Wace LLP now owns 901,645 shares of the financial services provider's stock valued at $43,459,000 after buying an additional 57,804 shares during the last quarter. Balyasny Asset Management L.P. boosted its holdings in Trupanion by 368.2% during the fourth quarter. Balyasny Asset Management L.P. now owns 841,254 shares of the financial services provider's stock worth $40,548,000 after purchasing an additional 661,559 shares during the last quarter. Northern Trust Corp boosted its holdings in Trupanion by 9.0% during the fourth quarter. Northern Trust Corp now owns 368,236 shares of the financial services provider's stock worth $17,749,000 after purchasing an additional 30,549 shares during the last quarter. BNP Paribas Financial Markets boosted its stake in Trupanion by 170.7% in the fourth quarter. BNP Paribas Financial Markets now owns 337,093 shares of the financial services provider's stock valued at $16,248,000 after acquiring an additional 212,545 shares during the last quarter. Finally, Kopion Asset Management LLC boosted its stake in Trupanion by 18.7% in the first quarter. Kopion Asset Management LLC now owns 281,072 shares of the financial services provider's stock valued at $10,476,000 after acquiring an additional 44,285 shares during the last quarter.
Trupanion Price Performance
Trupanion stock traded down $0.39 during midday trading on Wednesday, reaching $50.27. 215,472 shares of the stock were exchanged, compared to its average volume of 604,225. The company's fifty day moving average is $51.19 and its 200-day moving average is $44.03. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.69 and a current ratio of 1.69. The firm has a market cap of $2.16 billion, a PE ratio of 193.33 and a beta of 1.78. Trupanion, Inc. has a 52 week low of $31.00 and a 52 week high of $57.90.
Trupanion (NASDAQ:TRUP - Get Free Report) last posted its earnings results on Thursday, August 7th. The financial services provider reported $0.22 earnings per share for the quarter, topping analysts' consensus estimates of ($0.03) by $0.25. The business had revenue of $353.56 million for the quarter, compared to analyst estimates of $346.73 million. Trupanion had a net margin of 0.81% and a return on equity of 3.31%. Trupanion's revenue was up 12.3% on a year-over-year basis. During the same quarter in the prior year, the firm posted ($0.14) EPS. On average, sell-side analysts forecast that Trupanion, Inc. will post 0.13 EPS for the current year.
Insider Buying and Selling
In other news, CFO Fawwad Qureshi sold 2,534 shares of the stock in a transaction on Thursday, May 29th. The shares were sold at an average price of $48.31, for a total value of $122,417.54. Following the transaction, the chief financial officer owned 3,545 shares of the company's stock, valued at $171,258.95. This represents a 41.68% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Margaret Tooth sold 4,000 shares of the stock in a transaction on Tuesday, May 20th. The stock was sold at an average price of $45.86, for a total transaction of $183,440.00. Following the completion of the transaction, the chief executive officer directly owned 118,784 shares in the company, valued at $5,447,434.24. The trade was a 3.26% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 11,562 shares of company stock valued at $544,870. Company insiders own 5.42% of the company's stock.
Wall Street Analyst Weigh In
Several research firms have recently issued reports on TRUP. Lake Street Capital lowered their price target on shares of Trupanion from $65.00 to $60.00 and set a "buy" rating on the stock in a research report on Friday, May 2nd. Piper Sandler boosted their price target on shares of Trupanion from $62.00 to $67.00 and gave the company an "overweight" rating in a research report on Friday, August 8th. Stifel Nicolaus boosted their price target on shares of Trupanion from $41.00 to $45.00 and gave the company a "hold" rating in a research report on Friday, August 8th. Finally, Cantor Fitzgerald began coverage on shares of Trupanion in a research report on Tuesday. They issued a "neutral" rating and a $47.00 price target on the stock. Three research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $54.17.
Read Our Latest Research Report on Trupanion
Trupanion Profile
(
Free Report)
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Recommended Stories

Before you consider Trupanion, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Trupanion wasn't on the list.
While Trupanion currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.